Guardant Health, Inc. Operating Income

Quick Answer

Guardant Health, Inc. reported Operating Income of -$437.25 million for fiscal year 2025.

Guardant Health, Inc. Operating Income — Annual History

Fiscal Year Operating Income YoY Change
2025 -$437.25M +1.4%
2024 -$443.59M +21.4%
2023 -$564.73M -3.7%
2022 -$544.38M -32.5%
2021 -$411.00M -61.2%
2020 -$254.95M -209.5%
2019 -$82.37M +11.4%
2018 -$92.94M -21.3%
2017 -$76.61M -74.7%
2016 -$43.85M

Quarterly Operating Income

Quarter Ending Operating Income YoY QoQ
September 30, 2025 -$98.99M +15.6% +7.0%
June 30, 2025 -$106.41M -5.8% +4.2%
March 31, 2025 -$111.04M -11.4% +5.4%
September 30, 2024 -$117.33M -3.3% -16.6%
June 30, 2024 -$100.62M +15.9% -0.9%
March 31, 2024 -$99.68M +25.6% +12.2%
September 30, 2023 -$113.54M +21.5% +5.1%
June 30, 2023 -$119.62M +8.2% +10.8%
  • Guardant Health, Inc. showed an increase of +1.4% in Operating Income compared to the prior fiscal year.
  • Over the 2016–2025 period, Guardant Health, Inc.’s operating income has declined by 897.2% (from -$43.85 million to -$437.25 million).
  • The most recent figure is from Guardant Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment